Age-related clonal hematopoiesis associated with adverse outcomes.
BACKGROUND: The incidence of hematologic cancers increases with age. These cancers are associated with recurrent somatic mutations in specific genes. We hypothesized that such mutations would be detectable in the blood of some persons who are not known to have hematologic disorders. METHODS: We anal...
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
Massachussetts Medical Society
2014
|
| _version_ | 1826299927212326912 |
|---|---|
| author | Jaiswal, S Fontanillas, P Flannick, J Manning, A Grauman, P Mar, BG Lindsley, R Mermel, C Burtt, N Chavez, A Higgins, J Moltchanov, V Kuo, F Kluk, M Henderson, B Kinnunen, L Koistinen, H Ladenvall, C Getz, G Correa, A Banahan, B Gabriel, S Kathiresan, S Stringham, H McCarthy, M |
| author_facet | Jaiswal, S Fontanillas, P Flannick, J Manning, A Grauman, P Mar, BG Lindsley, R Mermel, C Burtt, N Chavez, A Higgins, J Moltchanov, V Kuo, F Kluk, M Henderson, B Kinnunen, L Koistinen, H Ladenvall, C Getz, G Correa, A Banahan, B Gabriel, S Kathiresan, S Stringham, H McCarthy, M |
| author_sort | Jaiswal, S |
| collection | OXFORD |
| description | BACKGROUND: The incidence of hematologic cancers increases with age. These cancers are associated with recurrent somatic mutations in specific genes. We hypothesized that such mutations would be detectable in the blood of some persons who are not known to have hematologic disorders. METHODS: We analyzed whole-exome sequencing data from DNA in the peripheral-blood cells of 17,182 persons who were unselected for hematologic phenotypes. We looked for somatic mutations by identifying previously characterized single-nucleotide variants and small insertions or deletions in 160 genes that are recurrently mutated in hematologic cancers. The presence of mutations was analyzed for an association with hematologic phenotypes, survival, and cardiovascular events. RESULTS: Detectable somatic mutations were rare in persons younger than 40 years of age but rose appreciably in frequency with age. Among persons 70 to 79 years of age, 80 to 89 years of age, and 90 to 108 years of age, these clonal mutations were observed in 9.5% (219 of 2300 persons), 11.7% (37 of 317), and 18.4% (19 of 103), respectively. The majority of the variants occurred in three genes: DNMT3A, TET2, and ASXL1. The presence of a somatic mutation was associated with an increase in the risk of hematologic cancer (hazard ratio, 11.1; 95% confidence interval [CI], 3.9 to 32.6), an increase in all-cause mortality (hazard ratio, 1.4; 95% CI, 1.1 to 1.8), and increases in the risks of incident coronary heart disease (hazard ratio, 2.0; 95% CI, 1.2 to 3.4) and ischemic stroke (hazard ratio, 2.6; 95% CI, 1.4 to 4.8). CONCLUSIONS: Age-related clonal hematopoiesis is a common condition that is associated with increases in the risk of hematologic cancer and in all-cause mortality, with the latter possibly due to an increased risk of cardiovascular disease. (Funded by the National Institutes of Health and others.). |
| first_indexed | 2024-03-07T05:09:22Z |
| format | Journal article |
| id | oxford-uuid:db07ba86-0fa2-49f9-81d1-3f8cd4495f59 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T05:09:22Z |
| publishDate | 2014 |
| publisher | Massachussetts Medical Society |
| record_format | dspace |
| spelling | oxford-uuid:db07ba86-0fa2-49f9-81d1-3f8cd4495f592022-03-27T09:07:42ZAge-related clonal hematopoiesis associated with adverse outcomes.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:db07ba86-0fa2-49f9-81d1-3f8cd4495f59EnglishSymplectic Elements at OxfordMassachussetts Medical Society2014Jaiswal, SFontanillas, PFlannick, JManning, AGrauman, PMar, BGLindsley, RMermel, CBurtt, NChavez, AHiggins, JMoltchanov, VKuo, FKluk, MHenderson, BKinnunen, LKoistinen, HLadenvall, CGetz, GCorrea, ABanahan, BGabriel, SKathiresan, SStringham, HMcCarthy, MBACKGROUND: The incidence of hematologic cancers increases with age. These cancers are associated with recurrent somatic mutations in specific genes. We hypothesized that such mutations would be detectable in the blood of some persons who are not known to have hematologic disorders. METHODS: We analyzed whole-exome sequencing data from DNA in the peripheral-blood cells of 17,182 persons who were unselected for hematologic phenotypes. We looked for somatic mutations by identifying previously characterized single-nucleotide variants and small insertions or deletions in 160 genes that are recurrently mutated in hematologic cancers. The presence of mutations was analyzed for an association with hematologic phenotypes, survival, and cardiovascular events. RESULTS: Detectable somatic mutations were rare in persons younger than 40 years of age but rose appreciably in frequency with age. Among persons 70 to 79 years of age, 80 to 89 years of age, and 90 to 108 years of age, these clonal mutations were observed in 9.5% (219 of 2300 persons), 11.7% (37 of 317), and 18.4% (19 of 103), respectively. The majority of the variants occurred in three genes: DNMT3A, TET2, and ASXL1. The presence of a somatic mutation was associated with an increase in the risk of hematologic cancer (hazard ratio, 11.1; 95% confidence interval [CI], 3.9 to 32.6), an increase in all-cause mortality (hazard ratio, 1.4; 95% CI, 1.1 to 1.8), and increases in the risks of incident coronary heart disease (hazard ratio, 2.0; 95% CI, 1.2 to 3.4) and ischemic stroke (hazard ratio, 2.6; 95% CI, 1.4 to 4.8). CONCLUSIONS: Age-related clonal hematopoiesis is a common condition that is associated with increases in the risk of hematologic cancer and in all-cause mortality, with the latter possibly due to an increased risk of cardiovascular disease. (Funded by the National Institutes of Health and others.). |
| spellingShingle | Jaiswal, S Fontanillas, P Flannick, J Manning, A Grauman, P Mar, BG Lindsley, R Mermel, C Burtt, N Chavez, A Higgins, J Moltchanov, V Kuo, F Kluk, M Henderson, B Kinnunen, L Koistinen, H Ladenvall, C Getz, G Correa, A Banahan, B Gabriel, S Kathiresan, S Stringham, H McCarthy, M Age-related clonal hematopoiesis associated with adverse outcomes. |
| title | Age-related clonal hematopoiesis associated with adverse outcomes. |
| title_full | Age-related clonal hematopoiesis associated with adverse outcomes. |
| title_fullStr | Age-related clonal hematopoiesis associated with adverse outcomes. |
| title_full_unstemmed | Age-related clonal hematopoiesis associated with adverse outcomes. |
| title_short | Age-related clonal hematopoiesis associated with adverse outcomes. |
| title_sort | age related clonal hematopoiesis associated with adverse outcomes |
| work_keys_str_mv | AT jaiswals agerelatedclonalhematopoiesisassociatedwithadverseoutcomes AT fontanillasp agerelatedclonalhematopoiesisassociatedwithadverseoutcomes AT flannickj agerelatedclonalhematopoiesisassociatedwithadverseoutcomes AT manninga agerelatedclonalhematopoiesisassociatedwithadverseoutcomes AT graumanp agerelatedclonalhematopoiesisassociatedwithadverseoutcomes AT marbg agerelatedclonalhematopoiesisassociatedwithadverseoutcomes AT lindsleyr agerelatedclonalhematopoiesisassociatedwithadverseoutcomes AT mermelc agerelatedclonalhematopoiesisassociatedwithadverseoutcomes AT burttn agerelatedclonalhematopoiesisassociatedwithadverseoutcomes AT chaveza agerelatedclonalhematopoiesisassociatedwithadverseoutcomes AT higginsj agerelatedclonalhematopoiesisassociatedwithadverseoutcomes AT moltchanovv agerelatedclonalhematopoiesisassociatedwithadverseoutcomes AT kuof agerelatedclonalhematopoiesisassociatedwithadverseoutcomes AT klukm agerelatedclonalhematopoiesisassociatedwithadverseoutcomes AT hendersonb agerelatedclonalhematopoiesisassociatedwithadverseoutcomes AT kinnunenl agerelatedclonalhematopoiesisassociatedwithadverseoutcomes AT koistinenh agerelatedclonalhematopoiesisassociatedwithadverseoutcomes AT ladenvallc agerelatedclonalhematopoiesisassociatedwithadverseoutcomes AT getzg agerelatedclonalhematopoiesisassociatedwithadverseoutcomes AT correaa agerelatedclonalhematopoiesisassociatedwithadverseoutcomes AT banahanb agerelatedclonalhematopoiesisassociatedwithadverseoutcomes AT gabriels agerelatedclonalhematopoiesisassociatedwithadverseoutcomes AT kathiresans agerelatedclonalhematopoiesisassociatedwithadverseoutcomes AT stringhamh agerelatedclonalhematopoiesisassociatedwithadverseoutcomes AT mccarthym agerelatedclonalhematopoiesisassociatedwithadverseoutcomes |